Upgrade to SI Premium - Free Trial

Autolus Therapeutics (AUTL) Deal with Blackstone Overall Positive - Mizuho

November 8, 2021 1:03 PM
Mizuho Securities analyst Mara Goldstein reiterated a Buy rating and $18.00 price target on Autolus Therapeutics (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles